FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA Moves on Peptides: What Compounding Pharmacies Need to Know The peptide problem: Hype is outrunning the evidence Is BPC 157 Banned? Oral vs. Injectable Forms Explained The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and